Published in Neuropathol Appl Neurobiol on August 01, 1996
Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol (2006) 1.01
The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression. Acta Neurol Scand (2011) 0.86
Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease. J Neural Transm (Vienna) (2005) 0.80
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet (1998) 3.08
Evolving quality in the new NHS: policy, process, and pragmatic considerations. Qual Health Care (1998) 2.99
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92
Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet (2000) 2.59
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000) 2.42
Inhibition of DNAse activity in PFGE analysis of DNA from Campylobacter jejuni. Lett Appl Microbiol (1994) 2.22
Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut (2008) 2.13
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia (2010) 2.03
Molecular subtyping scheme for serotypes HS1 and HS4 of Campylobacter jejuni. J Clin Microbiol (1995) 2.01
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
High-resolution genotyping of Campylobacter coli identifies clones of epidemiologic and evolutionary significance. J Infect Dis (1995) 1.80
Flagellin gene polymorphism analysis of Campylobacter jejuni infecting man and other hosts and comparison with biotyping and somatic antigen serotyping. Epidemiol Infect (1994) 1.68
Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol (1996) 1.66
Influences on clinical practice: the case of glue ear. Qual Health Care (1999) 1.62
Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51
Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. Clin Neuropathol (2001) 1.49
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia (2010) 1.45
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol (2007) 1.41
Experimental Amyloidosis in the Guinea Pig. Science (1949) 1.40
Progressive ataxia, focal seizures, and malabsorption syndrome in a 41 year old woman. J Neurol Neurosurg Psychiatry (1996) 1.39
Creutzfeldt-Jakob disease: implications for gastroenterology. Gut (2002) 1.38
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30
Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26
The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol (2005) 1.22
Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br J Cancer (1994) 1.18
Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis (1993) 1.18
Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol (1998) 1.17
An analysis of the diagnostic accuracy of the Hawkins and Neer subacromial impingement signs. J Shoulder Elbow Surg (2000) 1.17
Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Respir J (2011) 1.17
Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. J Pharm Pharmacol (1988) 1.16
Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet (1994) 1.14
Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13
The efficacy of magnetic resonance imaging in acute knee injuries. Clin J Sport Med (2000) 1.13
A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol (2009) 1.10
Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (1999) 1.09
Proprioception in anterior cruciate ligament-deficient and reconstructed knees. Am J Sports Med (1997) 1.09
Bovine spongiform encephalopathy and risk to health. BMJ (1992) 1.08
Neuropathology of spongiform encephalopathies in humans. Br Med Bull (1993) 1.08
DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg (1987) 1.07
Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol (2000) 1.05
The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry (2010) 1.04
Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS (1996) 1.04
Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol (1994) 1.04
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial. Eur J Cancer (2010) 1.02
Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol (1986) 1.01
Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol (1999) 0.98
Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. J Neurochem (1989) 0.98
Pulmonary veno-occlusive disease. A report of four cases. Histopathology (1986) 0.98
Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet (1993) 0.98
Histology of neuroblastoma involving bone marrow. Br J Haematol (1989) 0.97
Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol (2004) 0.97
Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol (2012) 0.97
Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype. Ann Neurol (2001) 0.97
Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet (2000) 0.96
Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet (2003) 0.96
Morphologic and immunophenotypic characterization of primary brain lymphomas using paraffin-embedded tissue. Histopathology (1989) 0.96
How to tackle a possible Creutzfeldt-Jakob disease necropsy. J Clin Pathol (1993) 0.96
Creutzfeldt-Jakob disease in a dairy farmer. Lancet (1995) 0.95
Quantitative videobronchoscopy: a new technique to assess airway caliber. Am J Respir Crit Care Med (1996) 0.95
Extra-skeletal Ewing's sarcoma of the nasal fossa. J Laryngol Otol (1990) 0.95
Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease. Neuropathol Appl Neurobiol (2008) 0.95
Transmission characteristics of tuberculosis in the foreign-born and the Canadian-born populations of Alberta, Canada. Int J Tuberc Lung Dis (2004) 0.95
RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue. Neuropathol Appl Neurobiol (2011) 0.94
Superficial epithelioid schwannoma presenting as a subcutaneous upper eyelid mass. Br J Ophthalmol (1994) 0.94
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry (2006) 0.93
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain (1999) 0.92
Neuronal apoptosis in fatal familial insomnia. Brain Pathol (1998) 0.92
Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie. Neuroreport (2001) 0.91
A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD). Neuropathol Appl Neurobiol (2009) 0.90
Analysis of proprioception in the posterior cruciate ligament-deficient knee. Knee Surg Sports Traumatol Arthrosc (1996) 0.90
Third ventricular chordoid glioma: clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features. Neuropathol Appl Neurobiol (2005) 0.90
High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1996) 0.90
Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours. J Neurooncol (1998) 0.90
A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harb Symp Quant Biol (1996) 0.90
Improving secondary prevention in coronary bypass patients: closing the audit loop. Heart (2005) 0.89
Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke (1999) 0.89
Paraganglioma of the cauda equina: a histological, ultrastructural and immunocytochemical study of two cases with a review of the literature. J Pathol (1985) 0.89
Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet (1997) 0.89
The new variant of Creutzfeldt-Jakob disease. Rev Sci Tech (2000) 0.88
Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry (1995) 0.88
Phase II study of tauromustine in malignant glioma. Eur J Cancer (1992) 0.88
An unusual case of Wilson's disease. Q J Med (1985) 0.87
True neurilemmoma arising in a lymph node in infancy. Histopathology (1991) 0.87
Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res (1990) 0.87
Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry (2006) 0.87
Retention of corneal epithelial cells following Goldmann tonometry: implications for CJD risk. Br J Ophthalmol (2003) 0.87
Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J Clin Pathol (1990) 0.87
In situ hybridization analysis of PrP mRNA in human CNS tissues. Neuropathol Appl Neurobiol (2001) 0.86
Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet (2001) 0.86